In this interview, Kim Wilson, Dassault Systèmes, explains the concepts of digital and virtual twins, and applies that first to the growing challenge of manufacturing cell and gene therapies efficiently and at scale. She considers the broader aspects of optimizing the supply chain, and how twins go much further than a CAD model when considering a new facility design. Twins have the potential to transform tech transfer, combination product design, and the industry’s whole understanding and approach to sustainability. So how can biomanufacturers get started – how does this relate to BioPhorum’s Digital Plant Maturity Model? Why has it not happened already? What are the obstacles and what are the main benefits to go for?
BioPhorum’s Digital Plant Maturity Model
Dassault Systems white paper: The virtual twin experience of the pharmaceutical process